ClinicalTrials.gov
ClinicalTrials.gov Menu

Toric Eye Strain and Stability Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01857102
Recruitment Status : Completed
First Posted : May 20, 2013
Results First Posted : May 15, 2017
Last Update Posted : June 19, 2018
Sponsor:
Information provided by (Responsible Party):
Johnson & Johnson Vision Care, Inc.

May 8, 2013
May 20, 2013
July 19, 2016
May 15, 2017
June 19, 2018
September 2013
June 2014   (Final data collection date for primary outcome measure)
  • Objective Comfort Assessed by Electromyography(EMG) [ Time Frame: 1 week ]
    Electromyography (EMG) utilizes electrodes affixed to the skin below the eyelid, which measures activity of the orbital portion of the orbicularis oculi muscle. The orbital portion of the orbicularis oculi muscle pulls on the skin of the forehead, temple and cheek and draws it toward a point at the edge of the orbit. This part of the muscle is mainly under voluntary control, and it what is contracted during the process of squinting. The palpebral portion of this muscle closes the eyelids. The EMG reading was performed while the subject was wearing contact lenses in order to objectively assess eyestrain.The higher the EMG reading indicated the more the eyestrain. The original EMG data collected from a 40-second recording consisted of approximately 40,000 observations; the machine read about 1000 observations per second consecutively during 40-second recording. The original EMG reading was converted to a single data point and entered in the EDC for the analysis purpose.
  • Visual Comfort [ Time Frame: 1-week follow-up ]
    The Visual comfort (diurnal fluctuation[DF]) scores were derived from the National Eye Institute Refractive Error Quality of Life (NEI-RQL) instruments- specifically the diurnal fluctuations sub-scale, by following the instruction given in the NEI-RQL-42 User Manual, Version 1.0. The NEI-RQL is a validated patient reported outcome questionnaire to assess the impact of refractive correction on vision specifically to quality of life. This survey consisted of 42 items used to develop 13 subscales: clarity of vision, expectations, near vision, far vision, diurnal fluctuations, activity limitations, glare, symptoms, dependence on correction, worry, suboptimal correction, appearance, and satisfaction with correction. An overall score is calculated by averaging the subscales. The overall scores can take on values of 0 to 100. Higher scores indicate better outcomes
Objective Comfort [ Time Frame: 1 week ]
Measured by electromyography
Complete list of historical versions of study NCT01857102 on ClinicalTrials.gov Archive Site
Not Provided
  • Monocular high contrast visual performance on LogMAR scale [ Time Frame: 1 week ]
  • Monocular low contrast visual performance on LogMAR scale [ Time Frame: 1 week ]
  • Monocular over refraction visual performance on LogMAR scale [ Time Frame: 1 Week ]
  • Monocular spherical aberration [ Time Frame: 1 week ]
    Assessed by aberrometry
  • Subjective assessment of visual comfort, eyestrain, fatigue [ Time Frame: 1 week ]
    Participants will respond to a sponsor provided questionnaire
  • Lens Fitting Efficiency and Timing [ Time Frame: 30 minutes ]
    Number of lens trials needed to determine an acceptable fit.
Not Provided
Not Provided
 
Toric Eye Strain and Stability Study
Not Provided
The purpose of this study is to determine the benefits of fitting low astigmats with soft toric contact lenses versus spherical contact lenses with regard to visual comfort, eyestrain, fitting efficiency, and visual performance.
Not Provided
Interventional
Not Applicable
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Astigmatism
  • Device: etafilcon A
    Soft contact lens to be worn in a daily wear, daily disposable modality for one week
  • Device: etafilcon A for Astigmatism
    Soft contact lens to be worn by participants in a daily wear, daily disposable modality for one week.
  • Active Comparator: etafilcon A/etafilcon A for Astigmatism
    Subjects were randomized to one of two sequences of lens wear.
    Interventions:
    • Device: etafilcon A
    • Device: etafilcon A for Astigmatism
  • Experimental: etafilcon A for Astigmatism/etafilcon A
    Subjects were randomized to one of two sequences of lens wear.
    Interventions:
    • Device: etafilcon A
    • Device: etafilcon A for Astigmatism
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
159
150
June 2014
June 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. The subject must have read, understand, and sign the statement of informed consent and receive a fully executed copy of the Informed Consent Form.
  2. The subject must appear able and willing to adhere to the instructions set forth in this protocol.
  3. The subject must be between 18 years and 45 years of age (inclusive).
  4. The subject must have best-corrected Snellen visual acuity of 20/30 or better in each eye.
  5. If the subject has ever worn contact lenses, the subject must be a current wearer of soft spherical contact lenses for at least 5 days/week and at least 8 hours/day during the month prior to enrollment.
  6. Subjective refraction must result in a vertex-corrected astigmatic contact lens prescription requiring at least -0.75 DC but not more than -1.75 DC cylindrical contact lens correction in each eye.
  7. Subjective refraction must result in a vertex-corrected spherical contact lens prescription between +0.25D to +4.00D or between-0.50D to -9.00D in each eye.
  8. The subject must not have the need for presbyopic correction (i.e., they must not be using as add in spectacles or wearing multifocal or monofocal contact lenses).
  9. The subject must have normal eyes with no evidence of abnormality or disease that in the opinion of the investigator would contraindicate contact lens wear.
  10. The subject must have access to the internet throughout the day (either desktop and/or smartphone) and be willing to answer a web-based survey within 1 hour of receiving a text message based notification throughout the day for up to 8 days, throughout the study duration.

Exclusion Criteria:

  1. Self-reported current pregnancy or lactation or plans to become pregnant during the study period (subjects who report becoming pregnant during the study will be discontinued)
  2. Any previous ocular or intra-ocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.)
  3. Any clinically meaningful slit lamp findings contraindicating contact lens wear (e.g. greater than or equal to grade 3 finding of edema, corneal neovascularization, corneal staining, conjunctival injection, blepharitis/meibomian gland dysfunction) on the FDA classification scale or any other ocular abnormality that in the opinion of the investigator may contraindicate contact lens wear.
  4. Any ocular infection
  5. Current use of topical ophthalmic medications other than artificial tears/rewetting drops.
  6. History of binocular vision abnormality or strabismus.
  7. Any infectious disease (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g. HIV) by self-report.
  8. Other active ocular disease that in the opinion of the investigator would contraindicate contact lens wear.
  9. Employee of the investigational clinic (e.g. investigator, coordinator, technician)
  10. Subject does not have a wearable pair of spectacles.
Sexes Eligible for Study: All
18 Years to 45 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01857102
CR-5363
No
Not Provided
Not Provided
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc.
Not Provided
Not Provided
Johnson & Johnson Vision Care, Inc.
May 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP